Advisor Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $108K | Buy |
3,929
+542
| +16% | +$14.9K | ﹤0.01% | 2883 |
|
|
2019
Q3 | $97K | Buy |
3,387
+2,334
| +222% | +$66.8K | ﹤0.01% | 2898 |
|
|
2019
Q2 | $30K | Buy |
1,053
+16
| +2% | +$456 | ﹤0.01% | 3691 |
|
|
2019
Q1 | $34K | Buy |
1,037
+85
| +9% | +$2.79K | ﹤0.01% | 3643 |
|
|
2018
Q4 | $27K | Buy |
952
+189
| +25% | +$5.36K | ﹤0.01% | 3606 |
|
|
2018
Q3 | $36K | Buy |
763
+53
| +7% | +$2.5K | ﹤0.01% | 3514 |
|
|
2018
Q2 | $26K | Sell |
710
-200
| -22% | -$7.32K | ﹤0.01% | 3544 |
|
|
2018
Q1 | $27K | Buy |
910
+100
| +12% | +$2.97K | ﹤0.01% | 3501 |
|
|
2017
Q4 | $28K | Buy |
810
+350
| +76% | +$12.1K | ﹤0.01% | 3484 |
|
|
2017
Q3 | $17K | Sell |
460
-607
| -57% | -$22.4K | ﹤0.01% | 3650 |
|
|
2017
Q2 | $28K | Buy |
1,067
+335
| +46% | +$8.79K | ﹤0.01% | 3261 |
|
|
2017
Q1 | $14K | Sell |
732
-71
| -9% | -$1.36K | ﹤0.01% | 3589 |
|
|
2016
Q4 | $14K | Buy |
803
+37
| +5% | +$645 | ﹤0.01% | 3450 |
|
|
2016
Q3 | $15K | Buy |
766
+310
| +68% | +$6.07K | ﹤0.01% | 3333 |
|
|
2016
Q2 | $13K | Buy |
+456
| New | +$13K | ﹤0.01% | 3331 |
|